相关实验视频
Updated: Jul 9, 2026

00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.3K
升高的介质素-18水平与乳腺甲状腺癌的淋巴结转移有关
Wang Chun1, Meiyin Lu2,3, Jiakang Chen1
1Pathology, Peking University Shenzhen Hospital, Shenzhen, China.
概括
干白素-18 (IL-18) 在乳头甲状腺癌 (PTC) 中升高,并与转移有关. 抑制IL-18可能是治疗侵略性PTC的一种策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 互乐金-18 (IL-18) 是一种参与免疫反应的益炎性细胞因子.
- IL-18 已显示出潜在的抗癌活性,但也可能促进癌症的进展.
- IL-18在乳头甲状腺癌 (PTC) 中的作用以前没有被研究过.
研究的目的:
- 研究IL-18在乳头甲状腺癌 (PTC) 中的表达和作用.
- 确定IL-18水平与PTC的临床病理特征之间的关联,特别是转移.
- 探索IL-18影响PTC进展的潜在机制.
主要方法:
- 比较PTC组织中的IL-18表达与正常甲状腺组织中的IL-18表达.
- 与淋巴血管侵入和淋巴结转移相关的IL-18表达和血清水平.
- 研究了IL-18和S100A10表达之间的关系,以及相关的信号通路.
主要成果:
- 与正常组织相比,IL-18表达在PTC显著增加.
- 升高的IL-18水平与淋巴血管侵入和淋巴结转移相关.
- IL-18可能通过调节S100A10并激活特定的免疫路径来促进PTC转移.
结论:
- IL-18表达在PTC上升调节,并与转移潜力相关.
- IL-18可能通过S100A10和免疫网络激活促进PTC进展.
- 抑制IL-18功能,而不是增强它,可能是对侵略性PTC的治疗策略.
更多相关视频
07:45Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
1.9K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
434
相关概念视频
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...